Flawed interpretative strategies for lung function tests harm patients [3]

European Respiratory Journal

Volumn 27, Issue 6, 2006, Pages 1322-1323

  Enright, P ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSENSUS; DISEASE SEVERITY; FALSE POSITIVE RESULT; FORCED EXPIRATORY VOLUME; HUMAN; LETTER; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LUNG VOLUME; PRIORITY JOURNAL; SPIROMETRY; STANDARDIZATION; VITAL CAPACITY; AIRWAY OBSTRUCTION; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; METHODOLOGY; NOTE; PREDICTION AND FORECASTING; STANDARD;

AIRWAY OBSTRUCTION; DIAGNOSIS, DIFFERENTIAL; FORCED EXPIRATORY VOLUME; HUMANS; LUNG VOLUME MEASUREMENTS; PREDICTIVE VALUE OF TESTS; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SPIROMETRY; VITAL CAPACITY;

EID: 33750722785     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00009006     Document Type: Letter

References (8)

1. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
2. American Thoracic Society Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202-1218.
3. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
4. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
5. National Collaborating Centre for Chronic Conditions Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary, secondary care, Thorax 2004; 59: Suppl. 1, 1-232.
6. Viegi G, Pedreschi M, Pistelli F, et al. Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition. Chest 2000; 117: Suppl. 2, 339S-345S.
7. Decramer M, Rutten-van Molken M, Dekhuijzen PN, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease: a randomised placebo-controlled trial. Lancet 2005; 365: 1552-1560.
8. Minnesota Evidence-based Practice Center of the Agency for Healthcare Research and Quality (AHRQ). Use of spirometry for case finding diagnosis, and management of chronic obstructive pulmonary disease (COPD). www.ahrq.gov/clinic/tp/spirotp.htm Last updated: August 2005. Last accessed: January, 5: 2006.